Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company is headquartered in Camana Bay, the Cayman Islands.
52W High
$341.99
52W Low
$170.99
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.21
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
47.17
EV/EBITDA (<8 favorable)
419.92
EV/Revenue (<3 favorable)
8.22
P/S (TTM) (<3 favorable)
8.59
P/B (<3 favorable)
9.97
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
17.24%
Institutions (25–75% balanced)
32.39%
Shares Outstanding
101,178,000
Float
872,799,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
4,562,002,000
Gross Profit (TTM)
3,809,693,000
EPS (TTM)
-1.67
Profit Margin (>10% good)
-0.04%
Operating Margin (TTM) (higher better)
0.07%
ROE (TTM) (>15% strong)
-0.05%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.42
Momentum
Bearish momentumValue
11.1052
Previous
12.4960
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025